Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Medtronic ( (MDT) ) has issued an update.
On September 15, 2025, Medtronic announced the pricing of a significant offering aimed at repaying existing senior notes due in 2025. The company plans to issue €1.5 billion in senior notes due in 2030 and 2045, which are fully guaranteed by Medtronic Luxco and Medtronic plc. This move reflects in Medtronic’s fiscal year 2026 earnings guidance and underscores its strategic financial management. Additionally, Medtronic Luxco has elected to redeem €500 million of its outstanding senior notes on September 29, 2025, contingent on the successful issuance of the new notes, indicating a proactive approach to managing its debt obligations.
The most recent analyst rating on (MDT) stock is a Hold with a $90.00 price target. To see the full list of analyst forecasts on Medtronic stock, see the MDT Stock Forecast page.
Spark’s Take on MDT Stock
According to Spark, TipRanks’ AI Analyst, MDT is a Outperform.
Medtronic’s overall stock score of 80 reflects strong financial performance and positive earnings call sentiment, supported by strategic corporate events. While the valuation is on the higher side, the company’s robust growth prospects and stable technical indicators contribute to a favorable outlook.
To see Spark’s full report on MDT stock, click here.
More about Medtronic
Medtronic plc is a leading company in the medical technology industry, specializing in the development and manufacturing of innovative medical devices and therapies. The company focuses on providing solutions for various medical conditions, enhancing patient care, and improving healthcare outcomes globally.
Average Trading Volume: 7,306,113
Technical Sentiment Signal: Buy
Current Market Cap: $119.8B
See more insights into MDT stock on TipRanks’ Stock Analysis page.